Literature DB >> 35359194

Does supplemental private health insurance incentivize household risky financial asset investment? Evidence from the China Household Financial Survey.

Si Shi1, Yawen Jiang2.   

Abstract

Private health insurance (PHI) is considered a supplement to public medical insurance schemes in China. To the extent that PHI coverage may offset background risk by decreasing medical expenditure risk, it may also incentivize risky financial behaviors. However, empirical evidence confirming this theory is absent in China. We fill this void by examining the impact of supplemental PHI on household risky financial investment using data from the China Household Financial Survey (CHFS). In the first set of analyses, we used bivariate probit (BVP) models with instrumental variables (IVs) to examine the effects of PHI on the extensive margin of household risky financial investment. In the second set of analyses, we used Tobit models with a two-stage residual inclusion (2SRI) framework to examine the effects of PHI on the corresponding intensive margin. The results indicated that supplemental PHI increased the probability of holding risky financial assets. On top of that, PHI increased the percentage of total financial assets allocated to risky financial investment. Such effects were more pronounced on stocks than on other risky products. Our findings provided evidence that purchasing supplemental PHI in China may increase the risk tolerance of financial investment, and risk attitude is a mediating factor between PHI ownership and risky financial investment behavior.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Background risk; China; Private health insurance; Risky financial investment; Stock

Year:  2022        PMID: 35359194     DOI: 10.1007/s10754-022-09326-9

Source DB:  PubMed          Journal:  Int J Health Econ Manag        ISSN: 2199-9031


  19 in total

1.  MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE.

Authors:  Dana Goldman; Nicole Maestas
Journal:  J Appl Econ (Chichester Engl)       Date:  2013-06-01

2.  The American health care system. Health insurance coverage.

Authors:  R Kuttner
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

3.  Monthly spending dynamics of the elderly following a health shock: Evidence from Singapore.

Authors:  Terence C Cheng; Jing Li; Rhema Vaithianathan
Journal:  Health Econ       Date:  2018-09-10       Impact factor: 3.046

4.  Trends in Total and Out-of-Pocket Expenditures for Visits to Primary Care Physicians, by Insurance Type, 2002-2017.

Authors:  Michael E Johansen; Jonathan D Y Yun
Journal:  Ann Fam Med       Date:  2020-09       Impact factor: 5.166

5.  Association Between Supplemental Private Health Insurance and Burden of Out-of-Pocket Healthcare Expenditure in China: A Novel Approach to Estimate Two-Part Model with Random Effects Using Panel Data.

Authors:  Yawen Jiang; Weiyi Ni
Journal:  Risk Manag Healthc Policy       Date:  2020-04-14

6.  Bringing scientific rigor to community-developed programs in Hong Kong.

Authors:  Cecilia S Fabrizio; Malia R Hirschmann; Tai Hing Lam; Teresa Cheung; Irene Pang; Sophia Chan; Sunita M Stewart
Journal:  BMC Public Health       Date:  2012-12-31       Impact factor: 3.295

7.  2SLS versus 2SRI: Appropriate methods for rare outcomes and/or rare exposures.

Authors:  Anirban Basu; Norma B Coe; Cole G Chapman
Journal:  Health Econ       Date:  2018-03-26       Impact factor: 2.395

8.  Impact of supplementary private health insurance on hospitalization and physical examination in China.

Authors:  Yawen Jiang; Weiyi Ni
Journal:  China Econ Rev       Date:  2020-07-03

9.  Risk selection into supplemental private health insurance in China.

Authors:  Yawen Jiang; Weiyi Ni
Journal:  Health Econ Rev       Date:  2019-12-17

10.  Determinants of Health Insurance Coverage among People Aged 45 and over in China: Who Buys Public, Private and Multiple Insurance.

Authors:  Yinzi Jin; Zhiyuan Hou; Donglan Zhang
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.